Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05653765

Prognostic Value of the AMR Measured After PPCI in STEMI Patients

Prognostic Value of the Angio-based Microvascular Resistance Use One Single Angiographic View Measured After Primary Percutaneous Coronary Intervention in ST-segment Elevation Myocardial Infarction Patients

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
2,663 (actual)
Sponsor
Henan Institute of Cardiovascular Epidemiology · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this observational study is to learn about in STEMI with Primary PCI Patients. The main questions it aims to answer are: * To determine the value of AMR in predicting the long-term clinical prognosis of patients with STEMI after PPCI, and to find the best cut-off value. * Analyze the factors of PPCI affecting AMR and explore the effective measures of PPCI microcirculation protection. Radiographic images of STEMI receiving primary PCI treatment in several chest pain centers in China will be included. The last image of the infarct-related vessel will be used as a target to calculate its AMR. The relationship between AMR and long-term clinical prognosis was analyzed.

Conditions

Timeline

Start date
2022-12-20
Primary completion
2023-12-20
Completion
2025-03-20
First posted
2022-12-16
Last updated
2025-03-17

Locations

5 sites across 1 country: China

Source: ClinicalTrials.gov record NCT05653765. Inclusion in this directory is not an endorsement.